Feasibility of HSCT vs consolidation therapy for AML patients aged 60-75 in CR1: A randomized phase III, multicentre EBMT study.

Dietger Niederwieser,Bob Löwenberg,Wolfgang E. Berdel,Ronald Brand,Yves Chalandon,Christian Junghanss,Dirk Hasenclever,Mathias Haenel,Georg Maschmeyer,Meinhard Mende,Mohamad Mohty,Gert Ten Ossenkoppele,Jakob Passweg,Herbert G. Sayer,Johannes Schetelig,Harry C. Schouten,Sebastian Schwind,Matthias Stelljes,Vladan Vucinic,Jan J. Cornelissen,Osho, Hovon, Sakk

Feasibility of HSCT vs consolidation therapy for AML patients aged 60-75 in CR1: A randomized phase III, multicentre EBMT study.

2018

7045Background: AML has a particularly dismal prognosis in the elderly population. The OSHO, HOVON, SAKK and the French AML study groups performed a randomized phase III study comparing Hematopoiet...

Keywords:

Physical therapy
Consolidation therapy
Medicine
Internal medicine
elderly population
study groups

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations